A 58-year-old man underwent upper lobectomy for primary pleomorphic carcinoma of the lung. Nine months later, the pleomorphic carcinoma was recurred with marked peripheral leukocytosis and an elevated C-reactive protein. Chest and abdominal computed tomography (CT) revealed enlarged mediastinal lymph nodes and a bulky tumor in the small intestine. An enterectomy was performed and the intestinal tumor was removed. Immunostaining revealed tumor cells positive for G-CSF and TNF-a as well as an increased level of serum G-CSF and TNF-a. We describe a rare case of G-CSF and TNF-a producing pleomorphic carcinoma of the lung with metastasis to the small intestine.
Introduction
Pleomorphic carcinoma of the lung is defined as a group of poorly differentiated non-small cell carcinoma that contains a component of sarcoma or sarcoma-like elements and shows carcinomatous as well as spindle and/or giant cell components. 1) Pleomorphic carcinoma of the lung is rare and accounts for less than 1% of all lung malignancies. 2) Although there have been several reports that some types of lung cancers produce various cytokines such as granulocyte colony-stimulating factor (G-CSF), interleukin 6 (IL-6), and IL-8, 3) there have been few reports of pleomorphic carcinoma of the lung producing these cytokines. We describe a rare case of G-CSF and tumor necrosis factor (TNF)-a producing pleomorphic carcinoma of the lung.
Case Report
A 58-year-old man complaining of cough and weight loss was treated at another hospital for a mass in the right upper lung with lesions invading the chest wall. The patient underwent upper lobectomy with partial rib resection, and a 30 × 33 mm tumor was completely removed. The patient was diagnosed with primary pleomorphic carcinoma of the lung, pT2aN0M0, stage IB, and did not undergo adjuvant chemotherapy. Nine months later, the patient was referred to our hospital with high fever and general fatigue. Laboratory testing showed marked peripheral leukocytosis (3.69 × 10 9 /L) and an elevated C-reactive protein (CRP, 18.59 mg/dL, normal range [NR] <0.25 mg/ dL). Serum concentrations of G-CSF and TNF-a were 83.4 pg/mL (NR <39 pg/mL) and 6.4 pg/mL (NR <2.8 pg/ mL), respectively. Chest and abdominal computed tomography (CT) revealed enlarged lymph nodes, including the subcarinal nodes (station 7) (Fig. 1A) , and a bulky tumor in the small intestine (Fig. 1B ). An enterectomy was performed and the intestinal tumor was removed. Histopathological examination of the excised tumor revealed a metastatic pleomorphic carcinoma, consisting of poorly differentiated adenocarcinoma with a spindle cell component ( Fig. 2A and 2B) . Immunostaining revealed tumor Multiple Cytokines-Producing Pleomorphic Carcinoma of Lung with Metastasis to the Small Intestine cells positive for G-CSF (Fig. 2C ) and TNF-a (Fig. 2D) . The clinical symptoms of the patient improved, and the levels of these plasma cytokines decreased for 2 months after the surgery. Despite intensive systemic chemotherapy, the patient died 4 months after the surgical removal of the intestinal metastasis.
Discussion
There have been several reports that some types of lung cancers produce various cytokines such as G-CSF, IL-6, TNF-a, and vascular endothelial growth factor (VEGF) in vitro. 3, 4) These cytokines are thought to have various effects on tumor growth and antitumor immune responses. G-CSF is a member of the CSF family of glycoproteins that control the survival, proliferation, differentiation, and functional activation of hematopoietic progenitor cells. Ectopic production of G-CSF is a cause of leukocytosis in solid tumors, including tumors of the lung, stomach, and urinary bladder. 5, 6) G-CSF is associated with tumor cell proliferation; it has been found to stimulate the clonal growth of nonhematopoietic tumor cells. 7) However, there have not been any reports of non-small cell lung cancer cells with G-CSF receptors (G-CSFR), which suggests that tumor proliferation does not occur through a G-CSF-dependent autocrine mechanism. In our patient, the tumor cells were also negative for G-CSFR and may therefore not have been susceptible to a G-CSF autocrine growth loop.
TNF-a is one of the most potent proinflammatory cytokines produced in the microenvironment of the tumor. TNF-a induces the activation of inhibitor kB kinase, which phosphorylates nuclear factor-kappa B (NFkB) inhibitor and triggers its rapid degradation through proteasome proteolysis, resulting in the liberation of NFkB. NFkB can then translocate to the nucleus where it activates the transcription of numerous immune system genes. 8) The contribution of NFkB signaling to the initiation and progression of cancer has been clearly documented, and several lines of evidence have demonstrated that TNF-a and NFkB signaling play key roles in the invasive/ metastatic spread of cancer cells. [9] [10] [11] To the best of our knowledge, this is the first case of a G-CSF and TNF-a producing pleomorphic carcinoma of the lung. Certain cytokines may be used as tumor markers in some cases of pleomorphic carcinoma of the lung. Elucidation of the function of these cytokines may lead to overcome the tolerance towards pleomorphic carcinoma of the lung.
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